Streetbeat News

Stock Prices

AMD

Financial giants have shown a bullish interest in Advanced Micro Devices (AMD) through significant options trading. Analysis reveals 38 unusual trades with a mix of bullish and bearish sentiments. The stock is currently trading at $155.09 with a neutral RSI, and earnings are expected in 7 days. Analysts have issued positive ratings with a consensus target price of $209.

Portfolio Pulse from Benzinga Insights

July 23, 2024 | 4:47 pm

BAC

Deep-pocketed investors have shown a bearish sentiment towards Bank of America (NYSE:BAC) through significant options activity. Benzinga's options scanner highlighted 22 extraordinary options activities, with a mix of bullish and bearish sentiments. Analysts have mixed ratings on BAC, with price targets ranging from $40 to $48.

Portfolio Pulse from Benzinga Insights

July 23, 2024 | 4:47 pm

BA

ITA

PPA

Boeing (NYSE: BA) shares are trading higher after announcing significant new orders, including 20 additional 777-9 planes from Qatar Airways and 20 737-8s from Macquarie AirFinance. Boeing also forecasts a 3% increase in airplane deliveries over the next 20 years. The stock has lost around 14% in the last 12 months but is seeing a positive short-term impact from these announcements.

Portfolio Pulse from Lekha Gupta

July 23, 2024 | 4:44 pm

NXPI

TXN

Texas Instruments (TXN) shares are down 2.9% ahead of its second-quarter earnings report, expected to show EPS of $1.17 on $3.82 billion in revenue. The decline is also influenced by NXP Semiconductors' (NXPI) mixed results and soft guidance, which may indicate broader issues in the semiconductor sector.

Portfolio Pulse from Henry Khederian

July 23, 2024 | 4:43 pm

FELE

Franklin Electric shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY24 EPS guidance.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 4:43 pm

JAGX

Jaguar Health, Inc. (NASDAQ:JAGX) shares are plummeting after the company announced that its phase 3 OnTarget trial for crofelemer did not meet its primary endpoint. The trial aimed to address diarrhea in cancer patients undergoing therapy but failed due to the heterogeneous nature of the patients. Despite this, some benefits were observed in patients with breast and respiratory cancers. The stock is experiencing heavy trading volume, with shares down 56.2% at $1.87.

Portfolio Pulse from Erica Kollmann

July 23, 2024 | 4:39 pm

TCNNF

New cannabis dispensaries are opening across the U.S., including Trulieve's new store in Pennsylvania, Dark Horse Cannabis's headquarters in Arkansas, Bloom Montana's new location in Bozeman, and Snoop Dogg's first licensed store near LAX. Trulieve is expanding its footprint in Pennsylvania, potentially positioning itself for recreational legalization.

Portfolio Pulse from Jelena Martinovic

July 23, 2024 | 4:39 pm

PRK

Park National shares are trading higher after the company reported better-than-expected Q2 EPS results.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 4:37 pm

CSTM

Constellium shares are trading lower after the company reported Q2 financial results and announced a pause in its FY24 adjusted EBITDA guidance due to flooding at its facilities.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 4:36 pm

GOOGL

LYFT

UBER

Waymo, a subsidiary of Alphabet Inc. (GOOGL), has launched its Zeekr robotaxi in San Francisco. This move marks a significant step in the autonomous vehicle industry, potentially impacting competitors like Uber (UBER) and Lyft (LYFT).

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 4:34 pm